Table II.

 Baseline Patient and Clinical Characteristics

Treatment Subgroup, mg	No.		SiDBP, mm Hg		SiSBP, mm Hg
	BMI, kg/m 2		BMI, kg/m 2		BMI, kg/m 2
	<30	≥30	<30	≥30	<30	≥30
Placebo	113	92	99.5	100.2	152.2	152.4
Nebivolol, 1.25	43	40	99.0	98.8	151.7	152.7
Nebivolol, 2.5	71	60	99.5	99.9	149.0	150.2
Nebivolol, 5	269	189	99.3	99.6	152.0	152.1
Nebivolol, 1	273	188	99.1	99.6	153.1	152.4
Nebivolol, 20	263	196	99.4	99.6	152.8	151.9
Nebivolol, 30/40	104	113	98.3	99.9	150.8	154.3

Abbreviations: BMI, body mass index; SiDBP, mean sitting diastolic blood pressure; SiSBP, mean sitting systolic blood pressure.